Diagnostic and prognostic roles of serum interleukin-32 (IL-32) levels in patients with pancreatic adenocarcinoma.


KARABULUT S. , Afsar C. U. , YASASEVER V., KARABULUT M., ERTURK K., ALIS H., ...Daha Fazla

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 3 - 07 Haziran 2016, cilt.34 identifier